Supernus

SUPN

29.7201.78% ( +0.520 )

Closed: Nov 13, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is 13.72, within the reasonable range, cheaper than 74.54% of the time in the past 5 years, and the industry ranks 21/257, the industry Median -0.95.

13.72xP/E

Stock price$29.72Earnings per share$2.17

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03876114152

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS	10.55x	5.54%	$183.56B
BMYUSBristol Myers Squibb	14.03x	52.15%	$129.66B
GSKUSGSK	17.77x	10.25%	$102.80B
OTSKYUSOtsuka Pharmaceutical	16.58x	--	$40.41B
HLNUSHaleon	18.62x	0.37%	$40.31B
ZTSUSZoetis	13.58x	5.15%	$34.06B
DSNKYUSDaiichi Sankyo	17.33x	--	$32.74B
ALPMYUSAstellas Pharma	12.46x	--	$30.21B
SGIOYUSShionogi	11.05x	--	$16.79B
OPHLYUSOno Pharmaceutical	15.51x	--	$7.28B
SUPNUSSupernus	13.72x	40.85%	$6.17B
SNPHYUSSanten Pharmaceutical	16.68x	--	$4.08B
OGNUSOrganon	17.14x	211.11%	$3.65B
PBHUSPrestige Brands	14.12x	11.34%	$2.19B
HRMYUSHarmony Biosciences	11.10x	35.38%	$1.98B
ANIPUSANI Pharma	14.79x	62.85%	$1.61B
PAHCUSPhibro Animal Health	14.22x	27.98%	$1.46B
GTBIFUSGreen Thumb Industries Inc.	14.38x	--	$1.42B
OMERUSOmeros	10.14x	1,913.34%	$1.27B
AMPHUSAmphastar Pharma	12.62x	6.90%	$1.25B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.